Background Early in 2020, mental health services had to rapidly shift from face-to-face
models of care to delivering the majority of treatments remotely (by video or phone call or …

Background The COVID-19 pandemic has exerted a significant toll on the lives of people
who use opioids (PWUOs). At the same time, more flexible regulations around provision of …

Social discourse about the opioid crisis in the US has focused on White populations, even
though opioid-related deaths have grown at a higher rate among people of color than …

Importance Early COVID-19 mitigation strategies placed an additional burden on individuals
seeking care for opioid use disorder (OUD). Telemedicine provided a way to initiate and …

Objective: The study examined temporal and geographic trends in telehealth availability at
US behavioral health treatment facilities and risk factors for not offering telehealth. Methods …

Background We conducted a scoping review focused on various forms of substance use
amid the pandemic, looking at both the impact of substance use on COVID-19 infection …

Methods| We analyzed data from OptumLabs Data Warehouse, 4 which includes claims for
commercial and Medicare Advantage enrollees who are overrepresented in the South and …

Objectives During the COVID-19 pandemic, opioid treatment programs (OTPs) in the US
were granted new flexibility in methadone dispensing and the use of telemedicine. To …

Background: A scoping review was conducted to examine the breadth of evidence related to
telehealth innovations being utilized in the treatment of opioid use disorder (OUD) with …

Objective: The authors examined the impact of COVID-19-related policies reducing barriers
to telehealth delivery of buprenorphine treatment for opioid use disorder (OUD) on …